US Stock MarketDetailed Quotes

IMCR Immunocore

Watchlist
  • 28.910
  • -1.400-4.62%
Close Dec 13 16:00 ET
  • 28.750
  • -0.160-0.55%
Post 16:48 ET
1.45BMarket Cap-30.43P/E (TTM)

Immunocore Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
109.41%21.13M
52,060.00%23.47M
-143.52%-4.59M
105.97%2.94M
-30.77%-17.73M
-21.72%10.09M
100.56%45K
126.02%10.54M
65.61%-49.21M
62.32%-13.56M
Net income from continuing operations
864.24%8.74M
31.73%-11.62M
-25.64%-24.44M
-5.22%-55.29M
43.06%-19.73M
-90.04%906K
-193.35%-17.01M
8.20%-19.45M
70.81%-52.54M
38.47%-34.65M
Operating gains losses
52.97%-5.39M
-97.64%100K
-81.91%1.3M
208.06%13.83M
37.07%13.84M
6.18%-11.45M
135.52%4.24M
480.74%7.21M
-13,025.25%-12.8M
3,152.66%10.09M
Depreciation and amortization
-3.90%1.04M
-3.60%992K
6.20%1.01M
-23.34%4.09M
5,698.40%1.03M
-19.04%1.08M
-43.39%1.03M
-56.84%952K
-29.72%5.34M
-103.82%-18.43K
Other non cash items
78.96%1.07M
245.39%1.39M
5.65%430K
-0.63%2.06M
130.20%652K
-51.46%599K
-68.19%401K
-76.56%407K
-9.83%2.07M
46.12%-2.16M
Change In working capital
67.39%18.01M
958.06%27.22M
-38.16%8.14M
123.93%5.78M
-491.54%-20.71M
10.99%10.76M
50.91%2.57M
141.05%13.16M
-10.05%-24.17M
-195.89%-3.5M
-Change in receivables
-365.39%-2.19M
25.97%-2.66M
-73.18%-6.2M
31.96%-17.87M
-709.73%-10.22M
87.41%-471K
60.50%-3.6M
76.29%-3.58M
-440.08%-26.26M
164.45%1.68M
-Change in prepaid assets
-178.94%-1.85M
8.09%-2.24M
-110.03%-1.82M
158.15%8.54M
---9.51M
--2.35M
---2.44M
--18.14M
-1,188.44%-14.69M
----
-Change in payables and accrued expense
263.09%25.92M
136.06%31.35M
979.37%16.85M
-10.62%41.71M
23.65%19.73M
-57.49%7.14M
-11.34%13.28M
247.25%1.56M
283.96%46.67M
99.18%15.96M
-Change in other current assets
----
----
-3,571.05%-1.4M
-217.45%-15.01M
---12.34M
----
----
---38K
-1,409.97%-4.73M
----
-Change in other current liabilities
-74.07%744K
-181.64%-707K
175.19%703K
-1,105.34%-3.58M
---6.38M
--2.87M
--866K
---935K
118.84%356K
----
-Change in other working capital
-105.98%-93K
----
----
68.58%-8.01M
3.30%-2M
146.31%1.55M
-33.89%-5.58M
87.51%-1.99M
12.27%-25.5M
67.71%-2.07M
Cash from discontinued investing activities
Operating cash flow
109.41%21.13M
52,060.00%23.47M
-143.52%-4.59M
105.97%2.94M
-30.77%-17.73M
-21.72%10.09M
100.56%45K
126.02%10.54M
65.61%-49.21M
62.32%-13.56M
Investing cash flow
Cash flow from continuing investing activities
-290.57%-828K
-25,013.33%-350.33M
85.67%-430K
-146.93%-5.43M
59.99%-817K
-181.67%-212K
-481.01%-1.4M
-1,617.72%-3M
-71.64%-2.2M
-78.63%-2.04M
Net PPE purchase and sale
-290.57%-828K
76.27%-331K
85.67%-430K
-146.93%-5.43M
33.69%-817K
46.30%-212K
-252.85%-1.4M
-1,617.72%-3M
-71.64%-2.2M
-9.73%-1.23M
Net investment purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-290.57%-828K
-25,013.33%-350.33M
85.67%-430K
-146.93%-5.43M
59.99%-817K
-181.67%-212K
-481.01%-1.4M
-1,617.72%-3M
-71.64%-2.2M
-78.63%-2.04M
Financing cash flow
Cash flow from continuing financing activities
-98.09%198K
-107.07%-818K
6,350.76%396.01M
-76.39%34.35M
-61.64%6.25M
-92.10%10.38M
2,333.27%11.58M
450.86%6.14M
-49.53%145.44M
52.90%16.3M
Net issuance payments of debt
--0
--0
--402.5M
--0
--0
--0
--0
--0
--0
-23.58%2.53M
Net common stock issuance
----
----
----
--0
----
----
----
----
-51.37%139.52M
152.52%9.07M
Proceeds from stock option exercised by employees
-98.09%198K
-97.43%298K
-6.27%5.75M
254.23%34.35M
35.06%6.25M
206.38%10.38M
766.68%11.58M
1,690.59%6.14M
647.00%9.7M
968.69%4.63M
Net other financing activities
--0
---1.12M
---12.24M
----
----
----
----
----
---3.77M
---3.34M
Cash from discontinued financing activities
Financing cash flow
-98.09%198K
-107.07%-818K
6,350.76%396.01M
-76.39%34.35M
-61.64%6.25M
-92.10%10.38M
2,333.27%11.58M
450.86%6.14M
-49.53%145.44M
52.90%16.3M
Net cash flow
Beginning cash position
16.90%504.99M
99.06%832.82M
9.98%442.63M
25.35%402.47M
14.56%444.14M
71.18%432M
54.72%418.38M
28.80%402.47M
81.75%321.08M
12.55%387.7M
Current changes in cash
1.20%20.5M
-3,304.04%-327.68M
2,758.78%391M
-66.12%31.86M
-1,858.29%-12.3M
-85.99%20.25M
216.32%10.23M
132.24%13.68M
-34.61%94.04M
102.64%699.32K
Effect of exchange rate changes
251.48%12.29M
-104.69%-159K
-135.91%-800K
165.58%8.29M
126.07%10.78M
-159.31%-8.11M
-76.93%3.39M
540.04%2.23M
-2,123.36%-12.65M
-7,078.59%-41.37M
End cash Position
21.08%537.77M
16.90%504.99M
99.06%832.82M
9.98%442.63M
9.98%442.63M
14.56%444.14M
71.18%432M
54.72%418.38M
25.35%402.47M
25.35%402.47M
Free cash flow
105.52%20.3M
1,814.15%23.14M
-166.56%-5.02M
95.17%-2.49M
-25.39%-18.55M
-20.94%9.88M
83.98%-1.35M
118.53%7.54M
64.42%-51.41M
59.35%-14.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 109.41%21.13M52,060.00%23.47M-143.52%-4.59M105.97%2.94M-30.77%-17.73M-21.72%10.09M100.56%45K126.02%10.54M65.61%-49.21M62.32%-13.56M
Net income from continuing operations 864.24%8.74M31.73%-11.62M-25.64%-24.44M-5.22%-55.29M43.06%-19.73M-90.04%906K-193.35%-17.01M8.20%-19.45M70.81%-52.54M38.47%-34.65M
Operating gains losses 52.97%-5.39M-97.64%100K-81.91%1.3M208.06%13.83M37.07%13.84M6.18%-11.45M135.52%4.24M480.74%7.21M-13,025.25%-12.8M3,152.66%10.09M
Depreciation and amortization -3.90%1.04M-3.60%992K6.20%1.01M-23.34%4.09M5,698.40%1.03M-19.04%1.08M-43.39%1.03M-56.84%952K-29.72%5.34M-103.82%-18.43K
Other non cash items 78.96%1.07M245.39%1.39M5.65%430K-0.63%2.06M130.20%652K-51.46%599K-68.19%401K-76.56%407K-9.83%2.07M46.12%-2.16M
Change In working capital 67.39%18.01M958.06%27.22M-38.16%8.14M123.93%5.78M-491.54%-20.71M10.99%10.76M50.91%2.57M141.05%13.16M-10.05%-24.17M-195.89%-3.5M
-Change in receivables -365.39%-2.19M25.97%-2.66M-73.18%-6.2M31.96%-17.87M-709.73%-10.22M87.41%-471K60.50%-3.6M76.29%-3.58M-440.08%-26.26M164.45%1.68M
-Change in prepaid assets -178.94%-1.85M8.09%-2.24M-110.03%-1.82M158.15%8.54M---9.51M--2.35M---2.44M--18.14M-1,188.44%-14.69M----
-Change in payables and accrued expense 263.09%25.92M136.06%31.35M979.37%16.85M-10.62%41.71M23.65%19.73M-57.49%7.14M-11.34%13.28M247.25%1.56M283.96%46.67M99.18%15.96M
-Change in other current assets ---------3,571.05%-1.4M-217.45%-15.01M---12.34M-----------38K-1,409.97%-4.73M----
-Change in other current liabilities -74.07%744K-181.64%-707K175.19%703K-1,105.34%-3.58M---6.38M--2.87M--866K---935K118.84%356K----
-Change in other working capital -105.98%-93K--------68.58%-8.01M3.30%-2M146.31%1.55M-33.89%-5.58M87.51%-1.99M12.27%-25.5M67.71%-2.07M
Cash from discontinued investing activities
Operating cash flow 109.41%21.13M52,060.00%23.47M-143.52%-4.59M105.97%2.94M-30.77%-17.73M-21.72%10.09M100.56%45K126.02%10.54M65.61%-49.21M62.32%-13.56M
Investing cash flow
Cash flow from continuing investing activities -290.57%-828K-25,013.33%-350.33M85.67%-430K-146.93%-5.43M59.99%-817K-181.67%-212K-481.01%-1.4M-1,617.72%-3M-71.64%-2.2M-78.63%-2.04M
Net PPE purchase and sale -290.57%-828K76.27%-331K85.67%-430K-146.93%-5.43M33.69%-817K46.30%-212K-252.85%-1.4M-1,617.72%-3M-71.64%-2.2M-9.73%-1.23M
Net investment purchase and sale --0------------------0----------------
Cash from discontinued investing activities
Investing cash flow -290.57%-828K-25,013.33%-350.33M85.67%-430K-146.93%-5.43M59.99%-817K-181.67%-212K-481.01%-1.4M-1,617.72%-3M-71.64%-2.2M-78.63%-2.04M
Financing cash flow
Cash flow from continuing financing activities -98.09%198K-107.07%-818K6,350.76%396.01M-76.39%34.35M-61.64%6.25M-92.10%10.38M2,333.27%11.58M450.86%6.14M-49.53%145.44M52.90%16.3M
Net issuance payments of debt --0--0--402.5M--0--0--0--0--0--0-23.58%2.53M
Net common stock issuance --------------0-----------------51.37%139.52M152.52%9.07M
Proceeds from stock option exercised by employees -98.09%198K-97.43%298K-6.27%5.75M254.23%34.35M35.06%6.25M206.38%10.38M766.68%11.58M1,690.59%6.14M647.00%9.7M968.69%4.63M
Net other financing activities --0---1.12M---12.24M-----------------------3.77M---3.34M
Cash from discontinued financing activities
Financing cash flow -98.09%198K-107.07%-818K6,350.76%396.01M-76.39%34.35M-61.64%6.25M-92.10%10.38M2,333.27%11.58M450.86%6.14M-49.53%145.44M52.90%16.3M
Net cash flow
Beginning cash position 16.90%504.99M99.06%832.82M9.98%442.63M25.35%402.47M14.56%444.14M71.18%432M54.72%418.38M28.80%402.47M81.75%321.08M12.55%387.7M
Current changes in cash 1.20%20.5M-3,304.04%-327.68M2,758.78%391M-66.12%31.86M-1,858.29%-12.3M-85.99%20.25M216.32%10.23M132.24%13.68M-34.61%94.04M102.64%699.32K
Effect of exchange rate changes 251.48%12.29M-104.69%-159K-135.91%-800K165.58%8.29M126.07%10.78M-159.31%-8.11M-76.93%3.39M540.04%2.23M-2,123.36%-12.65M-7,078.59%-41.37M
End cash Position 21.08%537.77M16.90%504.99M99.06%832.82M9.98%442.63M9.98%442.63M14.56%444.14M71.18%432M54.72%418.38M25.35%402.47M25.35%402.47M
Free cash flow 105.52%20.3M1,814.15%23.14M-166.56%-5.02M95.17%-2.49M-25.39%-18.55M-20.94%9.88M83.98%-1.35M118.53%7.54M64.42%-51.41M59.35%-14.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data